Latest news with #personalizedcare
BBC News
10 hours ago
- Health
- BBC News
Firm raises funds to help William Harvey Hospital grant wishes
A construction firm in Kent has raised almost £50,000 to help a hospital grant wishes to patients in its critical care have supported East Kent Hospitals Charity with funding for its 3 Wishes project at the William Harvey Hospital in Ashford since then, staff have been able to grant 222 wishes, ranging from transport to bring people together for the last hours of a loved one's life to creating mementoes like hand prints and manager Natalie Daly said: "It is a real privilege to be able to grant the wishes of our patients and their families at such a heart-breaking time. "Families tell us it makes a real difference and it is an honour to be able to provide truly personalised care that reflects what was important to their loved one throughout their life." 'Most difficult moments' Bauvill has raised funds through events for staff and partners, including a charity football director Matt Gurr said: "The project resonates deeply with us, not just because of the care it provides during life's most difficult moments, but because we've seen first-hand the compassion and dedication of the clinical teams behind it."Knowing our fundraising has helped make hundreds of final wishes possible is incredibly humbling, and something we're immensely proud of."A woman whose husband died was able to say goodbye to him in the unit's garden, with his favourite music said: "It was devastating, but a nice way to say goodbye. I feel the project offers so much comfort in a very sad time."Jane Kirk-Smith, critical care matron, added: "Each of those 222 wishes represents an incredibly special moment for a family losing a loved one."Words simply are not enough to thank the Bauvill team for their ongoing support in making those moments possible."
Daily Mail
17 hours ago
- Health
- Daily Mail
New test taken two weeks after starting treatment for breast cancer can tell if the disease is likely to return
A new test taken two weeks after starting treatment for breast cancer can tell if the disease is likely to return. The breakthrough could spare thousands of patients unnecessary therapy while allowing others to receive more intensive care sooner. Researchers at The Institute of Cancer Research, London, found taking hormone drugs for a fortnight changed the characteristics of some tumours, causing them to shift their subtype. Patients with the highest risk of relapsing had a type of tumour called Luminal B that did not change after this short-term therapy. These cases, accounting for 6 per cent of the 213 patients studied, require more intensive treatment that others could avoid. Experts say the findings, published in the journal eBioMedicine, highlight the benefit of taking hormone therapy before surgery to help guide doctors' decision making. The new test works for a type of breast cancer known as oestrogen receptor positive, human epidermal growth factor receptor 2 positive, of which there are around 200,000 cases globally each year. Study author Dr Maggie Cheang, from the ICR, said: 'To deliver truly personalised care, we need to refine how we classify breast cancer, so that each patient receives the treatment most likely to benefit them. 'While current classification relies on hormone receptor and HER2 status, we know that patients within these groups can respond very differently to the same therapy. 'Our earlier research identified distinct molecular subtypes within HER2-positive, oestrogen receptor-positive breast cancer. 'In this new study, we've shown that these subtypes can shift after just two weeks of hormone therapy. 'This insight helps us identify which patients are likely to respond well and which may show early signs of treatment resistance, offering the opportunity to tailor treatment strategies sooner. 'Ultimately, our findings move us closer to more precise, patient-centred care for this overlooked breast cancer subtype.' Professor Kristian Helin, chief executive of the IRC, added: 'By decoding the underlying biology of tumours, we can tailor treatments to individual patients.' Dr Simon Vincent, chief scientific officer at charity Breast Cancer Now, which part-funded the study, said: 'These findings add to the growing evidence that genomic testing can play a powerful role in helping to predict the risk of a woman's breast cancer coming back, particularly in people with ER-positive, HER2-positive breast cancer. 'There's potential for women to benefit hugely from this research in the future, with it ensuring they avoid undergoing unnecessary treatment and leading to more personalised treatment plans, so that women receive the most effective therapy for their specific type of breast cancer.'
Associated Press
19-06-2025
- General
- Associated Press
Fetch Me Later Celebrates Over 25 Years of Serving North Texas Dog Owners
Luxury pet resort in McKinney, Texas continues commitment to personalized care for dogs across Collin County and surrounding communities. MCKINNEY, TX, UNITED STATES, June 19, 2025 / / -- Fetch Me Later, a family-owned pet resort in McKinney, has reached a significant milestone, celebrating over 25 years of service to dog owners across North Texas since opening in 1998. Fetch Me Later, located on Highway 380 between Coit Road and Custer Road, operates on 12 wooded acres in McKinney and has built its reputation on providing individualized care for canine guests. The facility serves dog owners in McKinney, Prosper, Frisco, Plano, Dallas, Richardson, Allen, Fairview, Melissa, and surrounding areas within a 10-mile radius of the 75071 zip code. The McGough family—Shawn, Denise, Connor, and Tyler—owns and operates the pet resort. Denise McGough, a certified pet first aid and CPR instructor, maintains an on-site presence at the facility most days. The family emphasizes their personalized approach as one of the few family-owned pet resorts in the area. 'We understand that every dog has his or her own personality, and we make sure to cater to each guest's unique needs,' said Mr. Ben Muehler, Community Relations representative for Fetch Me Later. The facility's approach centers on treating each dog with individual attention based on their specific temperament and requirements. Customer feedback reflects the facility's focus on personalized care. Alexis C., a client, stated: 'My little pup loves getting groomed here and they did a phenomenal job both times we have been so far. It's hard to find a good groomer and they truly care here! We love it!' The pet resort's longevity in the McKinney market coincides with ongoing growth in the pet care industry. According to industry data, pet owners increasingly seek specialized boarding and grooming services that provide individualized attention for their animals. Angela T., another customer, described her experience: 'Our picky pups love it at Fetch Me Later. I've had negative experiences with other places, but always positive with Fetch Me Later. My dogs get SO EXCITED to go and are happy when I bring them home. Win win!' The facility's staff training includes specialized certification programs. The business maintains professional affiliations, including membership in the International Boarding & Pet Services Association as a Bronze Member in 2025 and membership with The Dog Gurus as of 2022. Over its 25-plus years of operation, Fetch Me Later has continuously enhanced both its facility and services. The pet resort's location provides a country setting within the McKinney area, featuring wooded acreage and green fields for outdoor activities. Nicole T., a regular client, shared her experience with the boarding services: 'Fetch Me Later is Amazing! Our dog has boarded here many times and he loves it! The staff are incredible and take such great care of our big fur baby. I wouldn't trust anyone else to care for our dog the way they do.' The anniversary milestone reflects the business's sustained presence in the North Texas pet care market. The facility continues to serve dog owners who value premium care services, maintaining its family-owned operational approach. Pet owners seeking more information about services can visit the facility for tours or contact Fetch Me Later at 972-562-9910. ### About Fetch Me Later: Fetch Me Later ( ) is McKinney's premier luxury pet resort nestled among 12 beautifully wooded acres and lush green fields. Located directly on Highway 380 between Coit Road and Custer Road, Fetch Me Later provides a country setting in the middle of McKinney where each guest is valued, loved, and treated as their own. The resort offers professional care that pet parents can trust, with staff committed to understanding and catering to each pet's unique personality and individual needs. Fetch Me Later maintains professional affiliations with industry organizations including The Dog Gurus, Pet Tech, and the International Boarding & Pet Services Association (IBPSA). 1943 Private Road 5312 McKinney, TX 75071 Notes to Editors: • Fetch Me Later is a member of respected industry organizations, including The Dog Gurus, Pet Tech, and the International Boarding & Pet Services Association (IBPSA). • The facility limits play groups to no more than six dogs at a time to ensure safety and personalized attention. • High-resolution images of the facility, including the Patio Suites, Pool View Suites, and play areas, are available upon request. • Fetch Me Later's expanded luxury boarding options come at a time when premium pet care services are seeing increased demand nationwide, as pet owners increasingly seek higher quality care options for their animals. • The resort's emphasis on customized care reflects the growing trend of personalized pet services in the industry. End of Press Release. Ben Muehler Fetch Me Later +1 972-562-9910 email us here Visit us on social media: LinkedIn Instagram Facebook Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
BBC News
30-05-2025
- General
- BBC News
Shropshire hospital trust launches dedicated home birth team
A dedicated home birth service has been launched by a Shropshire NHS trust. Shrewsbury and Telford Hospital NHS Trust (SaTH) announced that a team of seven midwives will provide 24-hour care to women and their families in Shropshire, Telford and Wrekin, and Mid Wales who choose to give birth at who opt to use the service will have a named midwife who will provide their antenatal and postnatal care. Tasha Simmons from SaTh said although the trust already offered home births, the dedicated team meant "greater personalised care" could be provided. "Families will get to know our team throughout pregnancy, and their experience will centre on collaborative decision-making and on birth preferences being safely supported."The trust said two midwives, including at least one from the new team wherever possible, would attend during labour. Paula Gardener, interim chief nursing officer, added: "Having a dedicated team of midwives ready to support the birth preferences of families in our communities means continuity of care and an opportunity for strong and trusting relationships to be forged". Follow BBC Shropshire on BBC Sounds, Facebook, X and Instagram.
The Sun
29-05-2025
- Health
- The Sun
‘Revolutionary test' that detects cancer up to a YEAR before it shows on scans to be rolled out on NHS in world first
SUPER sensitive cancer blood tests will be rolled out to NHS patients in a world first. People diagnosed with breast or lung cancers will be tested for circulating tumour DNA, known as ctDNA, to find fragments of disease in their blood. 1 Results will give doctors a quick read on their cancer type, speeding up access to specialised treatment with higher chances of success. Clinics typically have to wait for the results of scans and surgical biopsies to be sure what they are seeing. New 'liquid biopsies' could also one day be used to stop cancer spreading, predict the risk of it coming back and guide treatment changes. Professor Peter Johnson, NHS England's director for cancer, said: 'Liquid biopsies are leading us into a new era of personalised cancer care. 'We are now able to expand the use of this revolutionary test on the NHS to help tailor treatment for thousands of patients across the country. 'It has the potential to help us scan the body in a single blood test to see where and how cancer may be developing and target it with speed and precision to help save more lives. 'We hope to roll it out for patients with other forms of cancer in the near future.' ctDNA tests will be offered to patients with advanced breast cancer that is not responding to treatment, and people with suspected non-small cell lung cancer. Following successful pilots, England is the first country to begin a mass rollout and will test thousands of Brits every year. It is hoped many will be spared from unnecessary tests, surgery or chemotherapy. NHS rolls out bowel cancer screening to 50 and 52-year-olds after Dame Debs' campaigning Dr Isaac Garcia-Murillas, from The Institute of Cancer Research, London, said: 'The potential for patient benefit and cost savings to the NHS is incredible. 'The main point is it's non-invasive so there is no need for tumour biopsies, which can be painful. 'And often by the time you have tested a tumour by imaging it has already grown. 'If you pick it up earlier you can intervene earlier and smaller tumours might respond better to drugs. 'This test allows you to see cancer cells that are undetectable on others.' The NHS blood testing could see lung cancer patients get the best treatment weeks earlier, compared to waiting for scans and biopsy results. Women with hard-to-treat breast cancer will have tumour DNA analysed to work out the best targeted approach. Research by Dr Garcia-Murillas last year found the blood tests can detect signs of cancer growing back up to a year before it shows on a scan. Doctors hope the blood testing will become so accurate and simple that it can be used to monitor tumours in near real time. Dr Julie Gralow, president of the American Society of Clinical Oncology, said: 'This is a cool way of not having to stick needles into wherever the cancer is to test it, but just drawing blood. 'It's live monitoring at a level that is actually much more specific and early than waiting for it to show up on scans.' Cancer tests currently available in the UK In the UK, several cancer screening programs and diagnostic tests are available, including blood tests, imaging scans, and biopsies. Screening programs for breast, cervical, and bowel cancers are offered to specific age groups, while other tests, like those for lung cancer and prostate cancer, are available through a doctor's referral or self-referral. Breast screening Offered to women aged 50 to 70, with self-referral for women over 70, using mammograms to detect early signs of breast cancer. Bowel screening Home test kits are sent to individuals aged 50 to 74 every two years, with the option for those over 75 to self-refer. Cervical screening Offered to women, some transgender men, and some non-binary people aged 25 to 64, using Pap tests and HPV tests to detect changes in the cervix. Prostate cancer screening There is no national screening program for prostate cancer in the UK due to the unreliability of the PSA test.
